Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Pavan Bachireddy et al.|New England Journal of Medicine|2016Cited by 595
Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cellsMasahiro Hirakawa, Jerome Ritz|JCI Insight|2016Cited by 137